Top Markets
#1 Cortex Cortex +173.56%
#2 GEKKO GEKKO +52.86%
#3 ADO Protocol ADO Protocol +18.11%
#4 Helium Helium +15.14%
#5 Audiera Audiera +13.49%
#6 o1.exchange o1.exchange +11.76%
#7 Bless Bless +11.68%
#8 Seeker Seeker +10.51%
#9 aelf aelf +9.98%
#10 Status Status +9.70%
Coin of the day
Cortex Cortex
設定
言語
日本
通貨
USD
テーマ
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
株式のランク #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
株価
$59.98
最終同期: 2024-12-13
時価総額
$1.22B
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Longboard Pharmaceuticals, Inc. (LBPH)

カテゴリー

Healthcare
Longboard Pharmaceuticals, Inc.（LBPH）の収益
Sep 2024 時点の収益 TTM: $8.00K
Longboard Pharmaceuticals, Inc. の最新の財務報告によると、現在の収益 (TTM) は $8.00K です。2022 年には 0.00 の収益があり、これは 2021 年の 0.00 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Longboard Pharmaceuticals, Inc. の収益履歴（2020 ～ 2026）
各年末の収益
年 収益 変化
2026 (TTM) $8.00K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 157,803,650.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 75,265,991.36%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B 196,803,989.28%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 27,849,900.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH